Empagliflozin enhances human and murine cardiomyocyte glucose uptake by increased expression of GLUT1

Diabetologia. 2019 Apr;62(4):726-729. doi: 10.1007/s00125-019-4819-z.
No abstract available

Keywords: Cardiomyocytes; Empagliflozin; GLUT1; Glucose; Heart failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Animals
  • Benzhydryl Compounds / pharmacology*
  • Gene Expression Regulation*
  • Glucose / metabolism*
  • Glucose Transporter Type 1 / metabolism*
  • Glucosides / pharmacology*
  • Humans
  • Male
  • Mice
  • Middle Aged
  • Myocytes, Cardiac / drug effects*
  • Young Adult

Substances

  • Benzhydryl Compounds
  • Glucose Transporter Type 1
  • Glucosides
  • SLC2A1 protein, human
  • Slc2a1 protein, mouse
  • empagliflozin
  • Glucose